Elevated circulatory levels of leptin and resistin impair therapeutic efficacy of dacarbazine in melanoma under obese state
ConclusionThese findings unraveled the involvement of adipokines (leptin and resistin) in melanoma progression, and more importantly, in the outcome of DTIC therapy.
Source: Cancer and Metabolism - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Eating Disorders & Weight Management | Melanoma | Obesity | Skin Cancer | Study